Sitemap

Subsidiaries

Partners

Contact

Company

Who We Are

• About Lilly

  • Alzheimer's

  • Cancer

  • Diabetes

  • Immunology

  • Obesity

  • Pain

  • Our History

  • Key Facts

  • Recognitions

  • Position Statements

  • 2023 Year in Review

• Key Facts

  • Our History

  • About Lilly

  • Our Pipeline

  • Current Medicines

  • All News

  • Alzheimer's

  • Cancer

  • Diabetes

  • Immunology

  • Obesity

  • Pain

• Recognitions

  • About Lilly

  • Empower a Diverse Workforce

• Powered by Purpose

Leadership

• Governance

  • Executive Committee

  • Board of Directors

  • 2023 Year in Review

  • Annual Report & Proxy Statement

  • About Lilly

• Executive Committee

  • David A. Ricks

  • Eric Dozier

  • Anat Hakim

  • Edgardo Hernandez

  • Patrik Jonsson

  • Lucas Montarce

  • Diogo Rau

  • Melissa S. Seymour

  • Daniel M. Skovronsky, M.D., Ph.D.

  • Jacob Van Naarden

  • Alonzo Weems

  • Anne E. White

  • Ilya Yuffa

  • Key Facts

  • Board of Directors

  • Governance

• Board of Directors

  • David A. Ricks

  • Ralph Alvarez

  • Katherine Baicker, Ph.D.

  • J. Erik Fyrwald

  • Mary Lynne Hedley, Ph.D.

  • Jamere Jackson

  • Kimberly H. Johnson

  • William G. Kaelin Jr., M.D.

  • Juan R. Luciano

  • Gabrielle Sulzberger

  • Karen Walker

  • Key Facts

  • Executive Committee

  • Governance

Policies & Reports

• Public Policy

  • Payments to Health Care Professionals

  • Political and Policy Participation

  • 2023 Year in Review

  • Governance

  • Operating Responsibly

  • Our Tax Principles

• Annual Report and Proxy Statement

  • Executive Committee

  • Board of Directors

• 2023 Year in Review

  • Our Clinical Development Pipeline

Science

Innovation

• Clinical Development Pipeline

• Research & Development

  • Alzheimer's

  • Cancer

  • Diabetes

  • Immunology

  • Obesity

  • Pain

  • Clinical Trials

  • Pipeline

  • Partners

  • Subsidiaries

• Genetic Medicines

  • Research & Development

• Principles of Medical Research

  • Research Ethics

  • Operating Responsibly

  • HCP Medical Information

• 100 Years of Insulin

  • History of Diabetes Research

Disease Areas

• Alzheimer's

  • Alzheimer's Disease Timeline

• Cancer

  • No Wasted Moments

  • Support is Everything

  • Bridging the Gap

  • MCL Treatments

  • Reimagining Equitable Cancer Care

  • Improving Access to Precision Cancer Care

  • Alzheimer's

  • Cancer

  • Diabetes

  • Immunology

  • Obesity

  • Pain

• Diabetes

• Immunology

  • Atopic Dermatitis

  • Learn More About Ulcerative Colitis

  • A Day in the Life with Ulcerative Colitis

• Obesity

• Pain

  • Destigmatizing Migraine with a Goal to Improve Patient Outcomes

Clinical Research

• Clinical Trials

• Diversity in Clinical Trials

  • Lilly's Diversity and Inclusion Programs

• Expanded Access

• CSR Synopses

Partners

• Collaborate With Us

• Scientific Areas of Interest

  • Connect with Us

  • Our Research Award Program

• Office of Alliance Management

• Lilly Research Award Program

Medicines

Safety

• Counterfeit Medicine

• Patient Safety

  • Our Commitment to Patient Safety

  • How to Report Adverse Events

  • Product Protection

  • FDA's Role

• Manufacturing & Quality

Our Medicines

• Current Medicines

• Historic Medicines

• Suggestions for Patients

  • HCP Medical Information

  • FDA's Role

  • Product Protection

  • How to Report Adverse Events

• Your Story Matters

Resources

• Lilly Insulin Access Programs

  • Our Portfolio of Current Medicines

  • Insulin Access

• LillyDirect™

• Lilly Insulin State Patient Assistance Programs

  • Lilly Colorado Insulin State Patient Assistance Program

  • Lilly Maine Insulin State Patient Assistance Program

  • Lilly Minnesota Insulin Safety Net Program

• Lilly Pricing Information

• The Lilly Answers Center

  • Product Protection

• Lilly Cares Foundation

Impact

Our Impact

• Overview

  • Increasing Access to Medicines

  • Improving Lives and Communities

  • Empowering a Diverse Workforce

  • Minimizing Our Environmental Impact

  • Operate Ethically and Responsibly

  • 2023 Year in Review

• Lilly Foundation

• Lilly Grant Office

Impact Areas

• Increase Access to Medicines

  • Our Approach to Access and Affordability

  • 2022 Updates: Lilly's Global COVID-19 Response

  • Equitable Access to Medicines in Low- and Middle-Income Countries

  • Life for a Child: Expanding Diabetes Care for Vulnerable Youth

  • Lilly Global Health: Diabetes Impact Project in Indianapolis

• Improve Lives and Communities

  • Our Approach to Community Engagement

  • Committing to the Indy Racial Equity Pledge

  • Global Day of Service

• Empower a Diverse Workforce

  • Our Racial Justice Commitment

  • Inclusion on Purpose

• Minimizing Our Environmental Impact

  • Lilly Solar Farm in Ireland Reducing Carbon Emissions

  • Your Environment Impacts Your Health

• Operate Ethically and Responsibly

Transparency

• State-Specific Requirements

  • Lilly Solar Farm in Ireland Reducing Carbon Emissions

  • Your Environment Impacts Your Health

News

Stories

• Caring

• Science

• Policy

• All Stories

Press Releases

• Recent

• Archives

Media

• All News

• Media Kits

  • Zepbound^® (tirzepatide)

  • Kisunla™ (donanemab-azbt)

  • Lilly Insulin is $35 or Less a Month

  • Jaypirca^® (pirtobrutinib)

  • Tempo™ Personalized Diabetes Management Platform

  • Retevmo^® (selpercatinib)

  • Lyumjev^® (insulin lispro-aabc)

  • Mounjaro^® (tirzepatide)

  • Verzenio^® (abemaciclib)

• Media Contacts

  • Lilly Corporate Social Media Guidelines

• Lilly Corporate Social Media Guidelines

Footer

Diversity

Suppliers

• Prospective Suppliers

• Accounts Payable

  • Accounts Payable Privacy Statement

  • New Supplier Onboarding and Supplier Information

  • PO Terms & Conditions

  • Invoicing

  • Payments

  • Contacting Accounts Payable

• Supplier Resources

  • Suppliers: Operating Responsibly

  • Pharmaceutical Marketer Price Disclosure Law: Vermont

• Supplier Diversity

Login

Contact

• Designated Alternate Contacts for Reporting Concerns (for Countries That Limit Hotline Reporting)

Terms of Use

Privacy Statement

Accessibility Statement